Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Mylan CEO to testify about EpiPen before Congress next week
The Pharmalot View By Ed Silverman Allergan CEO looks smart for pledging to rein in prices. But will it make a difference?
Pharmalot By Ed Silverman Q&A: Allergan’s CEO speaks out on limiting drug prices. ‘Somebody had to take the first step’
Pharmalot By Ed Silverman Allergan CEO promises to limit price hikes on drugs in a bid to rebuild the ‘social contract’
Pharmalot By Ed Silverman To split or not to split? One Wall Street wag thinks Pfizer may remain intact
Pharmalot By Ed Silverman After failed Allergan merger, Pfizer once again considers splitting up the company
Pharmalot By Ed Silverman Treasury’s new rules on tax inversions raise questions about Pfizer-Allergan deal
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Pfizer and Allergan merge, Shkreli’s drug discount